Clinical Trial Update: Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India

View source ↗

Summary

A post-approval observational study in India to evaluate the safety and effectiveness of Octocog alfa (Kovaltry) in patients with severe Hemophilia A. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• Kovaltry (octocog alfa)

Snippet

Sponsor: Bayer | Conditions: Severe Hemophilia A | Status: NOT_YET_RECRUITING